Psychiatric comorbidities in patients with major depressive disorder

Código QR

Psychiatric comorbidities in patients with major depressive disorder

Papan Thaipisuttikul, Pichai Ittasakul, Punjaporn Waleeprakhon, Pattarabhorn Wisajun, Sudawan Jullagate Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Background: Psychiatric comorbidities are common in major depressive disorder (MDD)....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/93104b4855eb4009b31f8851940ca607
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version
por: Waleeprakhon P, et al.
Publicado: (2014)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
por: Fontani V, et al.
Publicado: (2011)

Comorbid personality disorders among patients with depression
por: Wongpakaran N, et al.
Publicado: (2015)

Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population
por: Kawamura S,&nbsp;Maesawa C,&nbsp;Nakamura K,&nbsp;Nakayama K,&nbsp;Morita M,&nbsp;Hiruma Y,&nbsp;Yoshida T,&nbsp;Sakai A,&nbsp;Masuda T
Publicado: (2011)

The influence of comorbid personality disorders on recovery from depression
por: Wongpakaran T, et al.
Publicado: (2015)

Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study
por: Ittasakul P, et al.
Publicado: (2020)

Psychiatric comorbidity and suicide risk in patients with chronic migraine
por: Maurizio Pompili, et al.
Publicado: (2010)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Psychogenic non-epileptic seizures: so-called psychiatric comorbidity and underlying defense mechanisms
por: Beghi M, et al.
Publicado: (2015)

Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey
por: Y&uuml;ce M, et al.
Publicado: (2013)

Coexistence of anxiety sensitivity and psychiatric comorbidities in patients with chronic tinnitus
por: Gül Aİ, et al.
Publicado: (2015)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
por: Abrahamian H, et al.
Publicado: (2012)

Saccadic eye movement applications for psychiatric disorders
por: Bittencourt J, et al.
Publicado: (2013)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: J Craig Nelson, et al.
Publicado: (2008)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
por: Tobe EH
Publicado: (2013)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis GA, et al.
Publicado: (2015)

Major depressive disorder: mechanism-based prescribing for personalized medicine
por: Saltiel PF, et al.
Publicado: (2015)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang X, et al.
Publicado: (2015)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang XF, et al.
Publicado: (2015)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez E, et al.
Publicado: (2014)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Bernhard T Baune
Publicado: (2008)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki A, et al.
Publicado: (2014)

Psychiatric disorders and traumatic brain injury
por: Marcelo Schwarzbold, et al.
Publicado: (2008)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
por: Jean-Michel Azorin, et al.
Publicado: (2010)

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
por: Armaly Z, et al.
Publicado: (2012)

Getting the balance right: Established and emerging therapies for major depressive disorders
por: Bojana Perovic, et al.
Publicado: (2010)

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
por: Han Y, et al.
Publicado: (2016)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Marty Hinz, et al.
Publicado: (2010)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Peter Hofmann
Publicado: (2010)

Tackling nonadherence in psychiatric disorders: current opinion
por: Farooq S, et al.
Publicado: (2014)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran A, et al.
Publicado: (2013)

Is placebo useful in the treatment of major depression in clinical practice?
por: Marchesi C, et al.
Publicado: (2013)

Association between toll-like receptor 4 expression and symptoms of major depressive disorder
por: Wu MK, et al.
Publicado: (2015)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir S, et al.
Publicado: (2015)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Psychiatric comorbidities in patients with intentional methanol intoxication
por: Yang WS, et al.
Publicado: (2019)

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
por: Kitaichi Y, et al.
Publicado: (2013)

Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
por: Singh M, et al.
Publicado: (2012)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
por: Berman R, et al.
Publicado: (2011)